WallStSmart

Aspire BioPharma, Inc. (ASBP)vsBorgWarner Inc (BWA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

BorgWarner Inc generates 14687591% more annual revenue ($14.34B vs $97,660). BWA leads profitability with a 2.9% profit margin vs 0.0%. BWA earns a higher WallStSmart Score of 65/100 (B-).

ASBP

Avoid

22

out of 100

Grade: F

Growth: 4.3Profit: 4.5Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -83.49

BWA

Strong Buy

65

out of 100

Grade: B-

Growth: 6.0Profit: 5.0Value: 8.7Quality: 7.0
Piotroski: 5/9Altman Z: 2.56
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASBP.

BWAUndervalued (+46.5%)

Margin of Safety

+46.5%

Fair Value

$102.66

Current Price

$55.93

$46.73 discount

UndervaluedFair: $102.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASBP1 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

BWA3 strengths · Avg: 8.7/10
PEG RatioValuation
0.3310/10

Growing faster than its price suggests

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
30.1%8/10

Earnings expanding 30.1% YoY

Areas to Watch

ASBP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.80M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

BWA4 concerns · Avg: 3.5/10
P/E RatioValuation
29.1x4/10

Moderate valuation

Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

Profit MarginProfitability
2.9%3/10

2.9% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ASBP

The strongest argument for ASBP centers on Price/Book.

Bull Case : BWA

The strongest argument for BWA centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.33 suggests the stock is reasonably priced for its growth.

Bear Case : ASBP

The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.

Bear Case : BWA

The primary concerns for BWA are P/E Ratio, Revenue Growth, Return on Equity. Thin 2.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

BWA carries more volatility with a beta of 1.14 — expect wider price swings.

BWA is growing revenue faster at 0.3% — sustainability is the question.

BWA generates stronger free cash flow (490M), providing more financial flexibility.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BWA scores higher overall (65/100 vs 22/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspire BioPharma, Inc.

CONSUMER CYCLICAL · AUTO PARTS · USA

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

Visit Website →

BorgWarner Inc

CONSUMER CYCLICAL · AUTO PARTS · USA

BorgWarner Inc. is an American multinational automotive supplier headquartered in Auburn Hills, Michigan.

Visit Website →

Want to dig deeper into these stocks?